Alphatec Holdings, Inc.

ATEC ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $-143.4M $-162.1M $-186.6M $-151.3M $-143.0M $-79.0M $-57.0M $-29.0M
Depreciation & Amortization $77.5M $78.4M $56.1M $41.2M $26.8M $10.9M $7.6M $6.8M
Depreciation $60.4M $62.1M $40.9M $31.0M $20.3M $9.2M $6.8M $6.0M
Amortization $15.1M $16.3M $14.3M $10.1M $5.3M $688.0K $698.0K $738.0K
Stock-Based Compensation $73.7M $73.3M $81.2M $40.6M $36.5M $17.7M $11.0M $5.3M
Net Cash from Operating Activities $45.2M $-44.7M $-78.5M $-75.1M $-73.3M $-46.4M $-33.1M $-25.6M
Investing Activities
Capital Expenditures $42.5M $83.2M $80.5M $49.5M $68.5M $23.1M $13.0M $6.5M
Business Acquisitions $0 $0 $55.0M — $62.1M — — $15.1M
Net Cash from Investing Activities $-53.4M $-93.1M $-142.0M $-58.3M $-157.8M $-23.9M $-13.0M $-21.7M
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — $25.0M — — —
Net Cash from Financing Activities $30.0M $56.2M $356.9M $31.2M $312.0M $130.8M $64.2M $53.9M
Net Change in Cash $22.0M $-82.1M $136.3M $-102.6M $79.5M $60.7M $18.1M $6.6M
Free Cash Flow $2.8M $-127.9M $-159.0M $-124.6M $-141.9M $-69.5M $-46.2M $-32.1M
← Newer Page 1 of 3 Older →